InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Neylan John F., Autre. Director active across 2 companies, notably Angion Biomedica Corp.. Cumulatively, 9 disclosures have been recorded. Split: 0 buy · 8 sells. Total volume traded: €23k. History available since 18 May 2021. The latest transaction was filed on 20 December 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Neylan John F.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
358 shares@ US$2.62013.7% of flowCommon StockSEC:0001601485-21-000091:0
374 shares@ US$4.136.0% of flowCommon StockSEC:0001601485-21-000077:0
373 shares@ US$8.6212.2% of flowCommon StockSEC:0001601485-21-000062:0
376 shares@ US$10.0714.2% of flowCommon StockSEC:0001601485-21-000058:0
381 shares@ US$9.0312.9% of flowCommon StockSEC:0001601485-21-000052:0
365 shares@ US$10.9815.0% of flowCommon StockSEC:0001601485-21-000038:0
366 shares@ US$13.2017.8% of flowCommon StockSEC:0001601485-21-000029:0
363 shares@ US$13.9118.2% of flowCommon StockSEC:0001601485-21-000025:0
53,750 sharesCommon StockSEC:0000899243-16-012464:0
9 of 9 declarations
About Neylan John F.
Neylan John F. is an executive at Angion Biomedica Corp.
